SiteOne Therapeutics (Series C)

Funding Details

Awarder

Inbox

Date Award

December 18, 2024

Vertical

Biopharmaceuticals

Funding URL

View Funding Page

Funding Amount:

$100,000,000

---

Company Info

Company Description

SiteOne Therapeutics is a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough, and other conditions.

Market

Pain, cough, and sensory hyperexcitability disorders

Location

South San Francisco, California, USA

Coinvestors

Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital, BSQUARED Capital, existing investors

---

Links

• Website